Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT-HN
NCT07851857Phase 3Recruiting
- Sponsor
- A.C.Camargo Cancer Center
- Start
- May 2025
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
A Phase 3 trial of ampicillin + sulbactam in surgical site infection (SSI), sponsored by A.C.Camargo Cancer Center. Started May 2025; status: recruiting.
02
Drugs
ampicillin + sulbactam
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07851857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07851857.